F. Antras, S. Laurent, M. Ahmar, H. Chermette, B. Cazes
FULL PAPER
diene (3b; 153 mg, 1.23 mmol) promoted by NMO (574 mg,
MS (EI): m/z (%) = 254 (64) [M]+, 183 (60), 170 (100), 155 (36),
4.9 mmol) in CH2Cl2/THF (1:1, 10 mL) gave, after flash 153 (33), 141 (32), 129 (20), 128 (32), 115 (34), 77 (28) [Ph+], 43
chromatography (PE/Et2O, 90:10), the cyclopentenones (E)-4eb
(86 mg, 48%), (Z)-4eb (37 mg, 20%) and 5eb (22 mg, 12%).
(20), 41 (34), 29 (31), 27 (24).
(Z)-4fb: Yellow oil; R = 0.33 (PE/Et O, 90:10). IR (thin film): ν =
˜
f
2
(E)-4eb: Yellow oil; R = 0.32 (PE/Et O, 90:10). IR (thin film): ν =
˜
3080, 3050, 3020, 2950, 2920, 2850, 1700 (C=O), 1600, 1490, 1120,
f
2
930, 760, 690 cm–1. 1H NMR (300 MHz, CDCl3): δ = 8.19 (s, 1 H,
2960, 2920, 2870, 1700 (C=O), 1590, 1460, 1380, 1300, 1050, 930,
730 cm–1. 1H NMR (300 MHz, CDCl3): δ = 7.37 (s, 1 H, 3-H),
4
3-H), 7.80 (dd, 3Jo = 8.1, Jm = 1.1 Hz, 2 H, 2ϫ Ho), 7.36 (m, 3
4
5.67 [tt, 3J = 7.4, Jtransoid = 1.7 Hz, 1 H, (C-4)=CHCH2], 2.91
3
H, 2ϫ Hm and 1ϫ Hp), 5.72 [t, J = 7.4 Hz, 1 H, (C-4)=CHCH2],
4
(d, Jtransoid = 1.7 Hz, 2 H, 5-H), 2.25 [q, 3J ≈ 7.4 Hz, 2 H, (C-4,
3.17 (s, 2 H, 5-H), 2.37 [q, 3J ≈ 7.4 Hz, 2 H, (C-4)=CHCH2], 1.66–
C=CHCH2)], 2.12 [t, 3J = 7.3 Hz, 2 H, (C-2)CH2], 1.58–1.22 (m,
10 H, 5ϫ CH2), 0.89 (t, 3J = 6.2 Hz, 6 H, 2ϫ CH3) ppm. 13C
NMR (50 MHz, CDCl3): δ = 205.9 (C-1, C=O), 154.3 (C-3), 146.7
(C-2), 136.2 (C-4), 128.6 [(C-4)=CH], 37.9 (C-5), 31.8, 30.1, 29.3
and 29.1 (4ϫ CH2), 26.5 [(C-2)CH2], 22.7 and 21.2 (2ϫ CH3CH2),
14.3 and 14.1 (2ϫ CH3) ppm. MS (EI): m/z (%) = 220 (62) [M]+,
191 (26) [M+ – C3H7], 149 (21), 136 (100), 121 (22), 108 (46), 107
(23), 93 (34), 91 (35), 79 (53), 77 (38), 65 (20). HRMS (EI): calcd.
for C15H26O [M]+ 220.1827; found 220.1822.
1.24 (m, 8 H, 4ϫ CH2), 0.90 (t, J = 6.6 Hz, 3 H, CH3) ppm. 13C
3
NMR (50 MHz, CDCl3): δ = 203.6 (C-1, C=O), 148.9 (C-3), 142.4
(C-2), 135.6 and 133.6 [C-4 and/or C(Ph)i], 130.0 [(C-4)=CHCH2],
128.4 [2ϫ CH(Ph)m and CH(Ph)p], 127.3 [2ϫ CH(Ph)o], 41.9 (C-
5), 31.7, 29.7, 28.9, 28.6 and 22.5 (5ϫ CH2), 14.2 (CH3) ppm. MS
(EI): m/z (%) = 254 (60) [M]+, 183 (70), 170 (100), 155 (36), 153
(54), 141 (40), 129 (38), 128 (29), 115 (41), 77 (28) [Ph]+, 43 (30),
41 (56), 29 (40), 27 (25).
5fb: Yellow oil; R = 0.50 (PE/Et O, 90:10). IR (thin film): ν =
˜
f
2
(Z)-4eb: Yellow oil; R = 0.26 (PE/Et O, 90:10). IR (thin film): ν =
˜
f
2
3080, 3050, 3020, 2950, 2920, 2850, 1700 (C=O), 1600, 1490, 1120,
930, 760, 690 cm–1. 1H NMR (300 MHz, CDCl3): δ = 7.90 (s, 1 H,
2960, 2920, 2870, 1700 (C=O), 1590, 1460, 1380, 1300, 1050, 930,
730 cm–1. 1H NMR (300 MHz, CDCl3): δ = 7.68 (s, 1 H, 3-H),
3
3-H), 7.84 (d, Jortho = 7.4 Hz, 2 H, 2ϫ Ho), 7.42–7.35 (m, 3 H,
4
5.55 [t, 3J = 7.8, Jcisoid ≈ 0.7 Hz, 1 H, (C-4)=CHCH2], 2.97 (d,
2ϫ Hm and 1ϫ Hp), 5.45 [br. s, 1 H, (C-4)=CHcis], 5.30 [br. s, 1
H, (C-4)=CHtrans], 3.02 (t, 3J = 5.4 Hz, 1 H, 5-H), 1.40–1.19 (m,
10 H, 5ϫ CH2), 0.86 (t, 3J = 6.6 Hz, 3 H, CH3) ppm. MS (EI):
m/z (%) = 254 (60) [M]+·, 183 (18), 170 (100), 155 (8), 153 (9), 141
(5), 55 (7).
4Jcisoid ≈ 0.7 Hz, 2 H, 5-H), 2.30 [m, 2 H, (C-4)=CHCH2], 2.12 [t,
3J = 7.3 Hz, 2 H, (C-2)CH2], 1.58–1.22 (m, 10 H, 5ϫ CH2), 0.89
3
(t, J = 6.2 Hz, 6 H, 2ϫ CH3) ppm. 13C NMR (50 MHz, CDCl3):
δ = 206.6 (C-1, C=O), 149.3 (C-3), 147.9 (C-2), 134.3 (C-4), 127.4
[(C-4)=CH], 40.8 (C-5), 31.7, 30.9, 28.4 and 27.6 (4ϫ CH2), 25.1
[(C-2)CH2], 22.7 and 22.5 (2ϫ CH3CH2), 14.1 and 14.0 (2ϫ CH3)
ppm. MS (EI): m/z (%) = 220 (100) [M]+, 191 (28) [M+ – C3H7],
149 (23), 136 (83), 121 (19), 108 (44), 107 (16), 93 (22), 91 (28), 79
(47), 77 (43), 65 (25).
2-tert-Butyl-4-heptylidenecyclopent-2-enone (4gb): (Table 6, entry 7)
Following procedure B, cycloaddition of the (3,3-dimethylbut-1-
yne)hexacarbonyldicobalt complex (2g; 385 mg, 1.05 mmol) with
nona-1,2-diene (3b; 196 mg, 1.57 mmol) promoted by NMO
(738 mg, 6.3 mmol) in CH2Cl2/THF (1:1, 12 mL) gave, after flash
chromatography (PE/Et2O, 95:5), the cyclopentenones (E)-4gb
(111 mg, 45%), (Z)-4gb (48 mg, 19%) and 5gb (14 mg, 6%).
5eb: Yellow oil; R = 0.45 (PE/Et O, 90:10). IR (thin film): ν =
˜
f
2
2960, 2920, 2870, 1700 (C=O), 1590, 1460, 1380, 1300, 1050, 930,
730 cm–1. 1H NMR (300 MHz, CDCl3): δ = 7.34 (s, 1 H, 3-H),
5.20 [br. s, 1 H, (C-4)=CHtrans], 5.08 [br. s, 1 H, (C-4)=CHcis], 2.76
(app t, 3J ≈ 5.3 Hz, 1 H, 5-H), 2.18 [t, 3J = 7.4 Hz, 2 H, (C-2)CH2],
(E)-4gb: Yellow oil; R = 0.40 (PE/Et O, 95:5). IR (thin film): ν =
˜
f
2
2960, 2920, 2850, 1700 (C=O), 1460, 1360, 1320, 980, 930 cm–1. 1H
NMR (300 MHz, CDCl3): δ = 7.33 (s, 1 H, 3-H), 5.65 [t, 3J =
7.4 Hz, 1 H, (C-4)=CHCH2], 2.90 (s, 2 H, 5-H), 2.11 [q, 3J
≈ 7.4 Hz, 2 H, (C-4)=CHCH2], 1.41–1.23 (m, 8 H, 4ϫ CH2), 1.21
3
1.48 [sextet, J = 7.4 Hz, 2 H, CH3CH2CH2(C-2)], 1.19 (m, 10 H,
3
3
5ϫ CH2), 0.87 (t, J = 7.4 Hz, 3 H, CH3), 0.80 (t, J = 6.2 Hz, 3
H, CH3 of hexyl) ppm. 13C NMR (50 MHz, CDCl3): δ = 208.9 (C-
1, C=O), 153.2 (C-3), 148.2 and 147.7 (C-2 and/or C-4), 109.4 [(C-
4)=CH2], 48.5 (C-5), 31.6, 29.8, 29.4, 26.8 and 25.2 (5ϫ CH2), 22.5
and 20.9 (2ϫ CH2CH3), 14.0 and 13.8 (2ϫ CH3) ppm. MS (EI):
m/z (%) = 220 (34) [M]+, 191 (37) [M+ – C3H7], 136 (35), 108 (15),
91 (16), 79 (33), 77 (31), 97 (15), 55 (100).
3
(s, 9 H, 3ϫ CH3), 0.88 (t, J = 7.0 Hz, 3 H, CH3) ppm. 13C NMR
(75 MHz, CDCl3): δ = 204.7 (C-1, C=O), 153.9 (C-3), 153.1 (C-2),
135.4 (C-4), 128.5 [(C-4)=CHCH2], 39.0 (C-5), 31.9 [C(tBu)], 31.7,
30.0, 29.2 and 29.0 (4ϫ CH2), 28.4 [3ϫ CH3(tBu)], 22.6
(CH2CH3), 14.1 (CH2CH3) ppm. MS (EI): m/z (%) = 234 (60)
[M]+, 219 (32) [M+ – CH3], 163 (26), 150 (100), 149 (21), 135 (35),
107 (21), 91 (21), 79 (19), 77 (21), 57 (20) [tBu]+, 55 (52).
4-Heptylidene-2-phenylcyclopent-2-enone (4fb): (Table 6, entry 5)
Following procedure B, cycloaddition of the phenylacetylene-hexa-
carbonyldicobalt complex (2f; 1.094 g, 2.82 mmol) with nona-1,2-
diene (3b; 526 mg, 4.23 mmol) promoted by NMO (1.980 g,
16.91 mmol) in CH2Cl2/THF (1:1, 14 mL) gave, after flash
chromatography (PE/Et2O, 90:10), cyclopentenones (E)-4fb
(306 mg, 43%), (Z)-4fb (136 mg, 19%) and 5fb (50 mg, 7%).
(Z)-4gb: Yellow oil; R = 0.32 (PE/Et O, 95:5). IR (thin film): ν =
˜
f
2
2960, 2920, 2850, 1700 (C=O), 1460, 1360, 1320, 980, 930 cm–1. 1H
NMR (300 MHz, CDCl3): δ = 7.63 (s, 1 H, 3-H), 5.52 [t, 3J =
7.4 Hz, 1 H, (C-4)=CHCH2], 2.94 (s, 2 H, C-5), 2.27 [q, 3J ≈ 7.4 Hz,
2 H, (C-4)=CHCH2], 1.41–1.23 (m, 8 H, 4ϫ CH2), 1.23 (s, 9 H,
3ϫ CH3), 0.88 (t, 3J = 7.0 Hz, 3 H, CH3) ppm. 13C NMR
(75 MHz, CDCl3): δ = 205.4 (C-1, C=O), 155.1 (C-2), 147.2 (C-3),
133.5 (C-4), 127.3 [(C-4)=CHCH2], 42.0 (C-5), 33.6 (CH2), 32.2
[C(tBu)], 29.7, 29.5 and 28.9 (3ϫ CH2), 28.3 [3ϫ CH3(tBu)], 22.6
(CH2CH3), 14.1 (CH2CH3) ppm. MS (EI): m/z (%) = 234 (100)
[M]+, 219 (43) [M+ – CH3], 191 (20), 107 (15), 149 (21), 135 (26),
107 (15), 77 (16), 57 (19) [tBu]+, 55 (46).
(E)-4fb: Yellow oil; R = 0.38 (PE/Et O, 90:10). IR (thin film): ν =
˜
f
2
3080, 3050, 3020, 2950, 2920, 2850, 1700 (C=O), 1600, 1490, 1120,
930, 760, 690 cm–1. 1H NMR (300 MHz, CDCl3): δ = 7.87 (s, 1 H,
4
3-H), 7.80 (dd, 3Jo = 8.1, Jm = 1.1 Hz, 2 H, 2ϫ Ho), 7.36 (m, 3
3
H, 2ϫ Hm and 1ϫ Hp), 5.88 [t, J = 7.4 Hz, 1 H, (C-4)=CHCH2],
3.12 (s, 2 H, 5-H), 2.22 [q, 3J ≈ 7.4 Hz, 2 H, (C-4)=CHCH2], 1.66–
3
1.24 (m, 8 H, 4ϫ CH2), 0.90 (t, J = 6.6 Hz, 3 H, CH3) ppm. 13C
NMR (50 MHz, CDCl3): δ = 203.5 (C-1, C=O), 154.5 (C-3), 141.5 5gb: Yellow oil; R = 0.48 (PE/Et O, 95:5). IR (thin film): ν = 2960,
˜
f
2
(C-2), 135.6 and 131.6 [C-4 and C(Ph)i], 131.3 (C=CHCH2), 128.4
2920, 2850, 1700 (C=O), 1460, 1360, 1320, 980, 930 cm–1. 1H NMR
[2ϫ CH(Ph)m and CH(Ph)p], 127.1 [2ϫ CH(Ph)o], 38.9 (C-5), 31.6, (300 MHz, CDCl3): δ = 7.35 (s, 1 H, 3-H), 5.24 [br. s, 1 H, (C-
3
30.3, 29.1 and 29.0 (4ϫ CH2), 22.6 (CH2CH3), 14.1 (CH3) ppm. 4)=CHtrans], 5.11 [br. s, 1 H, (C-4)=CHcis], 2.78 (t, J = 5.5 Hz, 1
3330
www.eurjoc.org
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
Eur. J. Org. Chem. 2010, 3312–3336